The Asthma Options Paradox
The introduction of a new treatment is a boon for any disease state.
Chronic Migraine, Chronic Insurer Denials
“It was so bad. It just wouldn’t quit.” Sara, a new patient, was sitting in my office describing a migraine attack that had led to a recent hospitalization.
Infants Aren’t the Only Ones Hurt by RSV
A seasonal respiratory virus that threatens the lives of infants also can have a ripple effect on caregivers, families and workplaces, a new data analysis demonstrates.
Can ICER Fix What’s Broken?
It’s that time again. The controversial Institute for Clinical and Economic Review is examining its value framework, the rules and assumptions it uses to analyze new drugs’ cost effectiveness.
Rheumatoid Arthritis Patients Want Tools for Shared Medical Decision-Making
When it comes to shared medical decision-making, European patients with rheumatoid arthritis are open to ideas.
Comments on ICER’s 2020 Value Assessment Framework
The conclusions from ICER’s cost-effectiveness evaluations can impact patients’ access to needed treatments. It is imperative, consequently, that ICER’s value assessment framework properly incorporates all potential benefits that a treatment can offer patients, including those benefits that are difficult to quantify or are unquantifiable. Read the Comments
Breakthrough Cystic Fibrosis Treatment on the Horizon
Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.
ICER’s Message of Hopelessness
The Institute for Clinical and Economic Review is dashing patients’ hopes yet again.
Health Plan Barriers & Migraine Are a Losing Combination
Migraine disease exists on a spectrum, presenting patients with different frequencies of attacks, whose duration and effect vary from person to person.
More than a Punchline
Most people have a stereotypical perception of Tourette syndrome. Likely based on a movie or TV show, their vision is of an uncontrollable stream of insults and curse words. On the screen, these symptoms become the joke, the punchline. Yet cliché portrayals of Tourette syndrome are not only oversimplified, but also harmful.
